The diagnostic use of procalcitonin for bacterial infections remains a matter of debate. Most
studies have used ambiguous outcome measures such as sepsis instead of infection. We …

Fever may be the only clinical symptom at the onset of infection in neutropenic cancer
patients undergoing myelosuppressive chemotherapy. A prompt and evidence-based …

Over the coming years, accelerating progress against cancer will be associated with an
increased number of patients who require life-sustaining therapies for infectious or toxic …

Sepsis is a major cause of mortality and morbidity in critically ill patients. Procalcitonin (PCT)
and C-reactive protein (CRP) are the most frequently used biomarkers in sepsis. We …

Up to 25% of patients with profound neutropenia lasting for> 10 days develop lung infiltrates,
which frequently do not respond to broad-spectrum antibacterial therapy. While a causative …

Purpose The study aims to determine the usefulness of procalcitonin (PCT) and other blood
markers for identification of bacterial infection among patients with febrile neutropenia (FN) …

Objective: To review the use of antibiotic stewardship interventions in the adult oncology and
hematopoietic cell transplantation (HCT) populations. Data Sources: A literature search of …

Background. Health professionals and researchers have become increasingly interested in
biomarkers that help them in diagnosis of infections with recent growing attention to …

In the context of emerging and increasing infections because of antimicrobial-resistant
bacteria in patients with neutropenic fever, quality improvement initiatives to reduce mortality …

Unlike bacterial infections, the value of procalcitonin (PCT) in detecting fungal infections in
leukaemia patients is not clear. To determine whether the monitoring of PCT coupled with C …